Goncalves Joana's Form 4 filing
Oruka Therapeutics, Inc. (ORKA) · filed Jun 15, 2026
- Accession no.
- 0000907654-26-000063
- Filed
- Jun 15, 2026
- Trade date
- Jun 15, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 2 derivative transactions. Open-market sales total $550.6K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Goncalves JoanaCIK 0001756991 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Common Stock | MOption exerciseAcquired | +3,500 | $6.84 | +$23,940 | 37,165 | Direct | |
| Jun 15, 2026 | Common Stock | MOption exerciseAcquired | +3,500 | $7.80 | +$27,300 | 40,665 | Direct | |
| Jun 15, 2026 | Common Stock | SSaleDisposed | −1,636 | $68.38 | −$111,869.68 | 39,029 | Direct | |
| Jun 15, 2026 | Common Stock | SSaleDisposed | −5,064 | $69.42 | −$351,542.88 | 33,965 | Direct | |
| Jun 15, 2026 | Common Stock | SSaleDisposed | −300 | $70.62 | −$21,186 | 33,665 | Direct | |
| Jun 15, 2026 | Common Stock | SSaleDisposed | −947 | $69.69 | −$65,996.43 | 32,718 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Common Stock | MOption exerciseDisposed | −3,500 | $0.00 | $0 | 204,063 | Direct | |
| Jun 15, 2026 | Common Stock | MOption exerciseDisposed | −3,500 | $0.00 | $0 | 175,492 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.